Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.4610
-0.0012 (-0.26%)
Jan 12, 2026, 10:40 AM EST - Market open

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
648010-
Upgrade
Market Cap Growth
-11514.72%-25.62%26.73%--
Upgrade
Enterprise Value
649111-
Upgrade
Last Close Price
0.464.1574.858083.83220059.883095808.38
Upgrade
PB Ratio
0.413.47-0.11-0.18-0.15-
Upgrade
P/TBV Ratio
0.433.47----
Upgrade
Debt / Equity Ratio
0.050.12-0.25-0.17-0.34-0.22
Upgrade
Quick Ratio
0.170.000.010.000.000.00
Upgrade
Current Ratio
2.451.500.010.010.010.00
Upgrade
Return on Equity (ROE)
-1236.83%-1163.67%----
Upgrade
Return on Assets (ROA)
-427.27%-363.36%-1447.01%-1564.19%-2626.42%-2029.40%
Upgrade
Return on Capital (ROIC)
-639.56%-559.26%----
Upgrade
Return on Capital Employed (ROCE)
-428.10%-407.60%41.30%57.30%66.80%59.10%
Upgrade
Earnings Yield
-1030.29%-122.28%-438.79%-476.99%-603.95%-
Upgrade
FCF Yield
-34.31%-0.84%-225.39%-198.15%-326.34%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.